• FDA warns top marijuana company for making CBD health claims

    1 month ago - By ABC News

    U.S. regulators issues warning to leading marijuana company for making unproven health claims about CBD
    Read more ...

     

  • FDA Warns Curaleaf Over CBD Products With Unfounded Claims

    1 month ago - By Medscape

    The FDA said the company is illegally marketing unapproved cannabidiol products they claim can treat cancer, Alzheimer's disease, opioid withdrawal, pain, and other conditions.
    News Alerts
    Read more ...

     

  • FDA commits to early fall update on CBD while it reaffirms enforcement stance

    FDA commits to early fall update on CBD while it reaffirms enforcement stance

    1 month ago - By NutraIngredients-USA

    FDA said today it will have an update on a new regulatory structure for CBD by early fall. The announcement came via a press release on another warning issued to a CBD marketer making illegal disease claims.
    Read more ...

     

  • FDA warns company for selling unapproved CBD products to treat Alzheimer's, cancer, opioid withdrawal

    1 month ago - By Healio

    The FDA has issued a warning letter to Curaleaf Inc. for illegally selling unapproved products containing cannabidiol, or CBD, online, claiming to treat Alzheimer's disease, cancer, opioid withdrawal, pain and other conditions, according to a press release.
    The FDA issued the warning letter because the company used product webpages, its online store and social media to make unproven and unapproved claims about more than a dozen different CBD products and their benefit regarding cancer, chronic pain, opioid withdrawal, pet anxiety and mental health disorders - such as Alzheimer's
    Read more ...